(Q33922875)

30 July 2017

1 reference

title

New paradigms for the treatment of cancer: the role of anti-angiogenesis agents (English)

1 reference

30 July 2017

1 reference

Cherrington JM

1

1 reference

30 July 2017

Strawn LM

series ordinal

2

1 reference

30 July 2017

Shawver LK

series ordinal

3

1 reference

30 July 2017

publication date

1 January 2000

1 reference

Advances in Cancer Research

30 July 2017

published in

1 reference

30 July 2017

volume

79

1 reference

30 July 2017

page(s)

1-38

1 reference

Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: Correlation with stage and rate of progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Role of interleukin-8 in tumor growth and metastasis of human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Roles of the matrix metalloproteinases in mammary gland development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: identification of multiple polyadenylation sites and a stromal pattern of expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Activity of type IV collagenases in benign and malignant breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Induction of tubulogenesis of microvascular endothelial cells by basic fibroblast growth factor from human SN12C renal cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

The influence of angiogenesis research on management of patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

What is the role of thymidine phosphorylase in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Microvessel count predicts metastatic disease and survival in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Neoangiogenesis: A putative marker of malignancy in non-small-cell-lung-cancer (NSCLC) development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Circulating vascular endothelial growth factor in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin-8 as a potential regulatory factor in breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Signaling vascular morphogenesis and maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Expression of fibroblast growth factor gene family and its receptor gene family in the human upper gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Interleukin-8 as a macrophage-derived mediator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: evidence of an autocrine pathway of platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Molecular mediators of tumor angiogenesis: Enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Signaling by integrin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

The regulation of neovascularization of matrix metalloproteinases and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Stromal angiogenesis in human glioma: a role of platelet-derived endothelial cell growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Interleukin-8 and de novo mammalian angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

The biochemistry of cancer dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Plasminogen activator system in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

1 reference

7 January 2021

Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

The effects of growth factors on the day 13 chorioallantoic membrane (CAM): a study of VEGF165 and PDGF-BB

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

The expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Matrix metalloproteinases. Novel targets for directed cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979001-4

7 January 2021

10.1016/S0065-230X(00)79001-4

Identifiers

DOI

1 reference

30 July 2017

1 reference